• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

eye disease

Close-up of Benjamin Franklins eyes peering through hundred dollar bills
Biotech

Lilly bags eye-catching gene therapy in $475M deal

The Indiana drugmaker will gain rights to a gene therapy that has restored vision in 11 children born legally blind.
Darren Incorvaia Nov 10, 2025 7:00am
Close-up of human eye

Opus sets sights on FDA talks after posting gene therapy data

Sep 30, 2025 9:15am
Two fencers spar in a stadium

Eye disease biotech launches with $100M, Roche rival in clinic

Sep 17, 2025 6:30am
Close-up of human eye

Opthea ramps up cuts to 85% of staff, including CEO

Aug 19, 2025 7:35am
eye eyeball eye art

Boehringer inks another eye disease deal, this time with Palatin

Aug 18, 2025 10:30am
pivot change turnaround direction walk away

Roche axes Carmot obesity asset, 3 cancer drugs in R&D clear-out

Jul 24, 2025 5:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings